This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Helen of Troy (HELE) Q3 Earnings Beat, Fiscal 2022 View Up
by Zacks Equity Research
Helen of Troy (HELE) Q3 reflects strong consumer and retailer demand for the Housewares and Beauty segments aiding core sales and earnings.
Helen of Troy (HELE) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 18.10% and 12.96%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
Factors to Note Before Helen of Troy's (HELE) Q3 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter fiscal 2022 results are likely to reflect escalated cost concerns, while strength in Leadership Brands is a key driver.
Helen of Troy (HELE) Adds Osprey, Strengthens Leadership Brands
by Zacks Equity Research
Helen of Troy (HELE) closes the buyout of Osprey Packs. It is likely to be an addition to the company's Leadership Brands' portfolio and is expected to augment the top and bottom lines.
Analysts Estimate Helen of Troy (HELE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Helen of Troy (HELE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
General Mills (GIS) Divests Yoplait, Boosts Accelerate Strategy
by Zacks Equity Research
General Mills (GIS) offloads 51% controlling interest in its European Yoplait operations to Sodiaal as part of its Accelerate strategy.
Archer Daniels (ADM) Acquires Sojaprotein to Meet High Demand
by Zacks Equity Research
In a bid to meet the growing demand for alternative protein, Archer Daniels (ADM) concluded the buyout of Sojaprotein. The move is expected to be accretive to its nutrition segment.
Brand Strength to Offset Monster Beverages (MNST) Cost Woes?
by Zacks Equity Research
Monster Beverages (MNST) is likely to keep gaining from strength in the energy drinks category and commitment toward product innovation. Supply & logistics woes are likely to persist in the near term.
Coty (COTY) Gains on Growth in Online Sales, Core Beauty Units
by Zacks Equity Research
Coty's (COTY) Prestige and Consumer Beauty categories are doing well, backed by strong brand offerings and innovations. The e-commerce platform is also gaining traction.
Here's Why Hold Strategy is Apt for Colgate (CL) Right Now
by Zacks Equity Research
Colgate (CL) benefits from a strong product portfolio, innovation and expansion strategies. Higher freight costs and commodity cost inflation remain concerns.
Here's Why Newell (NWL) is Marching Ahead of Its Industry
by Zacks Equity Research
Although cost woes remain concerning, robust consumption patterns, higher demand and solid online show are likely to aid Newell (NWL).
Coty (COTY) On Track to Simplify Capital Structure With KKR Move
by Zacks Equity Research
Coty (COTY) announces the sale of KKR's 2.4% remaining ownership stake in the company. The move will further simplify Coty's balance sheet and reduce cost of capital.
Solid Nutrition Unit to Aid Archer Daniels (ADM) Amid Cost Woes
by Zacks Equity Research
Despite cost woes, Archer Daniels (ADM) is likely to continue gaining from healthy demand, strength in the Nutrition unit and other growth efforts, including its Readiness program.
Here's Why You Should Hold Procter & Gamble (PG) for Now
by Zacks Equity Research
Procter & Gamble (PG) remains well-poised on the back of brand strength, solid top-line growth and cost-saving plans. However, higher-than-anticipated commodity and freight costs are concerning.
Nu Skin (NUS) Q3 Earnings Beat Estimates, Revenues Down
by Zacks Equity Research
Nu Skin's (NUS) third-quarter 2021 earnings and revenues decline year over year on disruptions caused by the Delta variant. Also, management lowered 2021 revenue guidance.
Clorox (CLX) Q1 Earnings and Sales Top Estimates, Decline Y/Y
by Zacks Equity Research
Clorox (CLX) Q1 results gain from strength across the portfolio and robust demand. Lower volume and unfavorable price mix have been headwinds.
The Estee Lauder Companies (EL) Beats on Earnings in Q1
by Zacks Equity Research
The Estee Lauder Companies' (EL) first-quarter fiscal 2022 sales and earnings rise year over year on growth in every region as well as product category.
Newell Brands (NWL) Beats on Q3 Earnings & Sales, Ups View
by Zacks Equity Research
Newell Brands' (NWL) third-quarter 2021 results are aided by solid demand, higher core sales and foreign-exchange tailwinds. It raises the 2021 sales view.
Service Corporation's (SCI) Q3 Earnings Top Estimates, View Up
by Zacks Equity Research
Service Corporation's (SCI) third-quarter 2021 results reflect solid earnings and sales, on strength in comparable preneed cemetery sales production and comparable preneed funeral sales production.
AB InBev (BUD) Q3 Earnings Lag Estimates, Revenues Beat
by Zacks Equity Research
AB InBev (BUD) reports top-line growth in Q3, driven by a favorable combination of volume and pricing. The bottom line reflects the impacts of higher costs and supply-chain disruptions.
Keurig Dr Pepper's (KDP) Q3 Earnings Meet, Sales Beat Estimate
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q3 results gain from increased consumer mobility, aiding away-from-home and fountain foodservice businesses. It raises the 2021 sales view.
Molson Coors (TAP) Stock Rises as Q3 Earnings Beat Estimates
by Zacks Equity Research
Molson Coors' (TAP) Q3 results reflect continued progress on its revitalization plan and premiumization efforts. Sales have been aided by strong pricing, and a favorable brand and channel mix.
Coca-Cola (KO) Rises as Q3 Earnings & Revenues Beat, Ups View
by Zacks Equity Research
Coca-Cola (KO) Q3 results gain from recovery across markets, strategic transformation, and improvements in at-home and away-from-home channels.
Archer Daniels (ADM) Surpasses Q3 Earnings & Revenue Estimates
by Zacks Equity Research
Archer Daniels' (ADM) Q3 results reflect gains from solid revenues across all segments, owing to healthy product demand. It expects strong momentum to continue in Q4.
Inter Parfums (IPAR) Raises 2021 View Again on Solid Q3 Sales
by Zacks Equity Research
Inter Parfums (IPAR) reported record sales numbers for the third quarter of 2021, reflecting impressive brand performance. Also, management revises 2021 view upward.